EXCESSIVE CONSUMPTION OF BLOOD COAGULATION COMPONENTS AS CAUSE OF HEMORRHAGIC DIATHESIS.
Explore the source record for details and available documents.
Blood Coagulation↗
Biomedical subjects
J VERMYLEN
Publications and source records attributed to J VERMYLEN.
ENHANCING BLOOD FIBRINOLYTIC ACTIVITY BY A NIACIN COMPOUND. II. ACTIVATION AND NONACTIVATION.
Explore the source record for details and available documents.
Biomedical Research↗
ON THE COMBINED ADMINISTRATION OF STREPTOKINASE AND PANCREATIC TRYPSIN INHIBITOR.
Explore the source record for details and available documents.
Blood Coagulation Tests↗
PRACTICAL METHOD FOR THROMBOLYTIC THERAPY WITH STREPTOKINASE. MAINTENANCE OF NEARLY COMPLETE PLASMINOGEN DEPLETION ASSOCIATED WITH HIGH CIRCULATING ACTIVATOR ACTIVITY.
Explore the source record for details and available documents.
Deoxyribonuclease I↗
ENZYMATIC CLOT DISSOLUTION IN MAN: A NEW THERAPEUTIC APPROACH.
Explore the source record for details and available documents.
Angiography↗
FURTHER EXPERIENCE WITH STREPTOKINASE AS THROMBOLYTIC AGENT.
Explore the source record for details and available documents.
Angiography↗
PITFALLS IN THE THROMBOLYTIC TREATMENT OF VENOUS OCCLUSION.
Explore the source record for details and available documents.
Angiography↗
EFFICACY OF THROMBOLYTIC THERAPY WITH STREPTOKINASE USING A NEW ADMINISTRATION SCHEME.
Explore the source record for details and available documents.
Angiography↗
FURTHER EXPERIENCE WITH STREPTOKINASE AS THROMBOLYTIC AGENT.
Explore the source record for details and available documents.
Deoxyribonuclease I↗
Feasibility of adequate thrombolytic therapy with streptokinase in peripheral arterial occlusions. I. Clinical and arteriographic results.
Explore the source record for details and available documents.
Arterial Occlusive Diseases↗
The streptokinase reactivity test. I. Standardization.
Explore the source record for details and available documents.
Deoxyribonuclease I↗
Influence of chlorpropamide and glucose on fibrinolytic activity.
Explore the source record for details and available documents.
Chlorpropamide↗
[CURRENT POSSIBILITIES AND COMPLICATIONS OF THROMBOLYTIC TREATMENT].
Explore the source record for details and available documents.
Cerebral Hemorrhage↗
Enhancing the fibrinolytic activity in human blood by occlusion of blood vessels. I. The appearance of the phenomenon.
Explore the source record for details and available documents.
Dental Occlusion↗
[On thrombolytic therapy].
Explore the source record for details and available documents.
Deoxyribonuclease I↗
[Methods for the measurement in vitro of spontaneous fibrinolytic activity in the venous blood of humans].
Explore the source record for details and available documents.
Fibrinolysis↗
[Indications for thrombolytic treatment].
Explore the source record for details and available documents.
Humans↗
[Thrombolytic substances and pharmacological agents used for fibrinolytic activity in the blood stream in increased coagulation time].
Explore the source record for details and available documents.
Fibrinolytic Agents↗